Australia markets closed

Surgery Partners, Inc. (SGRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.02+1.27 (+4.13%)
At close: 04:00PM EDT
32.02 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.07B
Enterprise value 7.04B
Trailing P/E 3.20k
Forward P/E 31.75
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.44
Price/book (mrq)2.07
Enterprise value/revenue 2.52
Enterprise value/EBITDA 14.81

Trading information

Stock price history

Beta (5Y monthly) 2.78
52-week change 3-17.11%
S&P500 52-week change 318.96%
52-week high 339.64
52-week low 322.05
50-day moving average 325.89
200-day moving average 328.47

Share statistics

Avg vol (3-month) 31.09M
Avg vol (10-day) 31.62M
Shares outstanding 5127.09M
Implied shares outstanding 6127.09M
Float 874.84M
% held by insiders 11.07%
% held by institutions 1109.49%
Shares short (15 July 2024) 412.27M
Short ratio (15 July 2024) 410.79
Short % of float (15 July 2024) 421.25%
Short % of shares outstanding (15 July 2024) 49.65%
Shares short (prior month 14 June 2024) 411.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.02%
Operating margin (ttm)12.60%

Management effectiveness

Return on assets (ttm)4.00%
Return on equity (ttm)4.76%

Income statement

Revenue (ttm)2.79B
Revenue per share (ttm)22.21
Quarterly revenue growth (yoy)7.70%
Gross profit (ttm)N/A
EBITDA 554.3M
Net income avi to common (ttm)600k
Diluted EPS (ttm)0.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)185.2M
Total cash per share (mrq)1.47
Total debt (mrq)3.17B
Total debt/equity (mrq)94.41%
Current ratio (mrq)1.71
Book value per share (mrq)15.57

Cash flow statement

Operating cash flow (ttm)260M
Levered free cash flow (ttm)149.59M